ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1426

The Effect of Anti-Interleukin-6 Receptor Antibody in Ovariectomized Mice

Sho Kato1, Hiroki Wakabayashi2, Taro Nakagawa3, Yohei Naito3, Takahiro Iino4 and Akihiro Sudo5, 1Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu City, Japan, 2Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu City, Japan, 3Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu City, Mie, Japan, 4Mie University Graduate School of Medicine, Mie University Graduate School of Medicine, Tsu City, Mie, Japan, 5Orthopaedic surgery, Mie University Postgraduate School of Medicine, Tsu-city, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: IL-6, osteoporosis and pain

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Pain: Basic and Clinical Aspects Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoporotic patients with no evidence of fractures sometimes experience vague low back pain. Bone pain associated with bone metastasis may also be related to increased osteoclastic bone resorption suggesting that osteoporosis-related bone pain is caused by increased osteoclastic bone resorption. J.Mysliwiec et al suggested that Interleukin-6 (IL-6) plays a considerable role of in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in estrogen-deficient women. In prospective study, IL-6 receptor inhibitor (IL-6Ri) increased the BMD of RA patients who had osteopenia. In addition, anti-IL-6R antibody inhibits systemic bone loss in the collagen-induced arthritis model mice. In this study, we investigated the effect of anti-IL-6R antibody on pain-related behavior and bone morphometry in ovariectomized mice.

Methods: 8-week-old female ddY mice were ovariectomized (OVX) and assigned to 3groups; SHAM-operated mice treated with vehicle (SHAM), OVX mice treated with vehicle (OVX), OVX mice treated with anti-IL-6R antibody  (IL-6Ri). Starting immediately after surgery, vehicle or 2mg anti-IL-6R antibody was injected subcutaneously once a week for 4 weeks. The bilateral proximal tibial metaphyses were analyzed three-dimensionally by μCT 4 weeks after surgery (each group; 8 mice). Mechanical sensitivity was tested using von Frey filaments 4 weeks after surgery. The frequency of the withdrawal response and the withdrawal threshold to the application of von Frey filaments to the planter surface of the hindpaws was examined. To evaluate the frequency of the withdrawal response, three von Frey filaments with forces of 0.4, 0.6 and 1.4 were applied 5 times each in ascending order of force, and the number and intensity of withdrawal responses were noted. Results were expressed as the percent response frequency of paw withdrawals. To evaluate the withdrawal threshold, each von Frey filament was applied once, starting with 0.008g and increasing until a withdrawal response was reached, which was considered a positive response. The lowest force producing a response was considered the withdrawal threshold.

Results:μCT analysis of the femoral distal metaphysis and the proximal tibial metaphysis showed that bone volume/tissue volume (BV/TV) and trabecular number (Tb.N) were significantly less in the OVX group than in the SHAM group, whereas trabecular separation (Tb.Sp) was significantly greater in the OVX group than in the SHAM group. IL-6Ri treatment was no effect on bone morphometry compared with OVX group. The withdrawal threshold was significantly lower in the OVX group than in the SHAM group, and was significantly improved in the IL-6Ri group than in the OVX group. The paw-withdrawal-frequency stimulated by von Frey filaments with strength of 0.4, 0.6 and 1.4 g was significantly higher in the OVX group than in the SHAM group, and von Frey filaments with strength of 1.4g was significantly higher in the OVX group than in the IL-6Ri group. Anti-IL-6R antibody improved mechanical hyperalgesia in hindlimbs. 

Conclusion: In this study, anti-IL-6R antibody prevented mechanical hyperalgesia in hindlimbs in hindlims of OVX mice, but did not prevent ovariectomy-induced bone loss.


Disclosure: S. Kato, None; H. Wakabayashi, None; T. Nakagawa, None; Y. Naito, None; T. Iino, None; A. Sudo, None.

To cite this abstract in AMA style:

Kato S, Wakabayashi H, Nakagawa T, Naito Y, Iino T, Sudo A. The Effect of Anti-Interleukin-6 Receptor Antibody in Ovariectomized Mice [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-effect-of-anti-interleukin-6-receptor-antibody-in-ovariectomized-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-anti-interleukin-6-receptor-antibody-in-ovariectomized-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology